Recent advances of cocktail chemotherapy by combination drug delivery systems

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Cancer statistics, 2014

Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499 · see citing works

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works

Folding DNA to create nanoscale shapes and patterns

Rothemund, P. W. K. (2006) · Nature · doi:10.1038/nature04586 · Cited by 7,391 · see citing works

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302 · see citing works

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · see citing works

New functions for the matrix metalloproteinases in cancer progression

Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108 · see citing works

Cancer treatment and survivorship statistics, 2016

Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066 · see citing works

Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature

Park, P. Y., Goldin, T. A., Chang, J. C. S., Markman, M. M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273 · see citing works

Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163 · see citing works

The resurgence of platinum-based cancer chemotherapy

Kèlland, L. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2167 · Cited by 4,733 · see citing works

Cancer nanotechnology: opportunities and challenges

Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · see citing works

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,876 · see citing works

Factors affecting the clearance and biodistribution of polymeric nanoparticles

Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · see citing works

Strategies in the design of nanoparticles for therapeutic applications

Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · see citing works

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works

Biodegradable polymeric nanoparticles as drug delivery devices

Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549 · see citing works

Long-Circulating and Target-Specific Nanoparticles: Theory to Practice

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521 · see citing works

Impact of Nanotechnology on Drug Delivery

Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,364 · see citing works

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · see citing works

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · see citing works

Cancer treatment and survivorship statistics, 2014

Desantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21235 · Cited by 2,781 · see citing works

Mechanisms of Cancer Drug Resistance

Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643 · see citing works

Magnetic nanoparticles in MR imaging and drug delivery

Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,595 · see citing works

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Tacar, O., Sriamornsak, P., & Dass, C. R. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,469 · see citing works

Childhood and adolescent cancer statistics, 2014

Ward, E., Desantis, C. E., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,416 · see citing works

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · see citing works

Chemotherapy and the war on cancer

Chabner, B. A., & Roberts, T. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1529 · Cited by 2,152 · see citing works

Death and anti-death: tumour resistance to apoptosis

Igney, F. H., & Krammer, P. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc776 · Cited by 2,073 · see citing works

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke‐Pearson, D. L., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,034 · see citing works

Drug Delivery and Targeting

Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,030 · see citing works

Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery

Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,932 · see citing works

Paclitaxel (Taxol)

Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924 · see citing works

Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)

Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806 · see citing works

The emerging nanomedicine landscape

Wagner, V., Dullaart, A., Bock, A., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,631 · see citing works

Magnetic nanoparticles for drug delivery

Arruebo, M., Fernández‐Pacheco, R., Ibarra, M. R., & Santamarı́a, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,630 · see citing works

Self-assembly of a nanoscale DNA box with a controllable lid

Andersen, E. S., Dong, M., Nielsen, M. M., Jahn, K., Subramani, R., Mamdouh, W., Golas, M. M., Sander, B. O., Stark, H., Oliveira, C. L. P., et al. (2009) · Nature · doi:10.1038/nature07971 · Cited by 1,628 · see citing works

Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications

Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,620 · see citing works

Molecular biomimetics: nanotechnology through biology

Sarıkaya, M., Tamerler, C., Jen, A. K. ‐., Schulten, K. J., & Baneyx, F. (2003) · Nature Materials · doi:10.1038/nmat964 · Cited by 1,597 · see citing works

Pharmacokinetics and Biodistribution of Nanoparticles

Li, S., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,570 · see citing works

Nanosuspensions in drug delivery

Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,528 · see citing works

Solid lipid nanoparticles for parenteral drug delivery

Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494 · see citing works

DNA and its associated processes as targets for cancer therapy

Hurley, L. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc749 · Cited by 1,350 · see citing works

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., Lena, M. D., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329 · see citing works

Small-scale systems for in vivo drug delivery

LaVan, D. A., McGuire, T., & Langer, R. (2003) · Nature Biotechnology · doi:10.1038/nbt876 · Cited by 1,301 · see citing works

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

Lee, H., Lytton‐Jean, A. K. R., Chen, Y., Love, K. T., Park, A. I., Karagiannis, E. D., Sehgal, A., Querbes, W., Zurenko, C., Jayaraman, M., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.73 · Cited by 1,168 · see citing works

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,072 · see citing works

Nanostructured materials for applications in drug delivery and tissue engineering

Goldberg, M. S., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,057 · see citing works

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers

Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,021 · see citing works

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Sergina, N. V., Rausch, M., Wang, D., Blair, J. A., Hann, B. C., Shokat, K. M., & Moasser, M. M. (2007) · Nature · doi:10.1038/nature05474 · Cited by 993 · see citing works

The common biology of cancer and ageing

Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988 · see citing works

Mechanisms of drug combinations: interaction and network perspectives

Jia, J., Zhu, F., Ma, X., Cao, Z., Li, Y. X., & Chen, Y. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 975 · see citing works

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

Wendel, H., de Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 956 · see citing works

The age of cancer

DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951 · see citing works

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Sengupta, S., Eavarone, D. A., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 946 · see citing works

Synergistic drug combinations tend to improve therapeutically relevant selectivity

Lehár, J., Krueger, A., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 941 · see citing works

Candidate mechanisms for chemotherapy-induced cognitive changes

Ahles, T. A., & Saykin, A. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2073 · Cited by 924 · see citing works

Trends and Developments in Liposome Drug Delivery Systems

Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 910 · see citing works

siRNAs: applications in functional genomics and potential as therapeutics

Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909 · see citing works

Liposomal Drug Delivery Systems: An Update Review

Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 909 · see citing works

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Gatzemeier, U., Pluzanska, A., Szczęsna, A., Kaukel, E., Roubec, J., Rosa, F. D., Milanowski, J., Karnicka-Mlodkowski, H., Pešek, M., Serwatowski, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1474 · Cited by 875 · see citing works

Tamoxifen: a most unlikely pioneering medicine

Jordan, V. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1031 · Cited by 832 · see citing works

Comparing antibody and small-molecule therapies for cancer

Imai, K., & Takaoka, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1913 · Cited by 794 · see citing works

The Chemotherapy Source Book

(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 787 · see citing works

Applications of nanotechnology for immunology

Smith, D. M., Simon, J. K., & Baker, J. R. (2013) · Nature reviews. Immunology · doi:10.1038/nri3488 · Cited by 768 · see citing works

Weekly nab -Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Socinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I. O., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 758 · see citing works

Nanoparticles: pharmacological and toxicological significance

Medina, C., Santos-Martínez, M. J., Radomski, A. D., Corrigan, O. I., & Radomski, M. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707130 · Cited by 741 · see citing works

Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy

Huang, P., Wang, D., Su, Y., Huang, W., Zhou, Y., Cui, D., Zhu, X., & Yan, D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505212y · Cited by 720 · see citing works

Polymers in drug delivery

Pillai, O., & Panchagnula, R. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00227-1 · Cited by 711 · see citing works

Cancer nanomedicine: from targeted delivery to combination therapy

Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693 · see citing works

The war on cancer

Sporn, M. B. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91015-6 · Cited by 692 · see citing works

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

Hu, C. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 688 · see citing works

Natural products in cancer chemotherapy: past, present and future

Mann, J. (2002) · Nature reviews. Cancer · doi:10.1038/nrc723 · Cited by 685 · see citing works

Enzyme-responsive nanomaterials for controlled drug delivery

Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 683 · see citing works

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 654 · see citing works

Identifying regulatory networks by combinatorial analysis of promoter elements

Pilpel, Y., Sudarsanam, P., & Church, G. M. (2001) · Nature Genetics · doi:10.1038/ng724 · Cited by 653 · see citing works

Anticancer Platelet‐Mimicking Nanovehicles

Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 631 · see citing works

Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies

Gerber, H., & Ferrara, N. (2005) · Cancer Research · doi:10.1158/0008-5472.671.65.3 · Cited by 626 · see citing works

Evolutionary dynamics of cancer in response to targeted combination therapy

Božić, I., Reiter, J. G., Allen, B., Tibor Antal, A., Chatterjee, K., Shah, P., Moon, Y. S., Yaqubie, A., Kelly, N. E., Le, D. T., et al. (2013) · eLife · doi:10.7554/elife.00747 · Cited by 607 · see citing works

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

Wang, H., Zhao, Y., Wu, Y. F., Hu, Y.-L., Nan, K., Nie, G., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.032 · Cited by 603 · see citing works

Cellular accumulation of the anticancer agent cisplatin: A review

Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 578 · see citing works

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 576 · see citing works

Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment

Hu, C. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564 · see citing works

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 563 · see citing works

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

Li, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562 · see citing works

Adverse effects of anticancer agents that target the VEGF pathway

Chen, H. X., & Cleck, J. N. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.94 · Cited by 560 · see citing works

Paclitaxel Nano-Delivery Systems: A Comprehensive Review

Ma, P. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000164 · Cited by 560 · see citing works

Seven challenges for nanomedicine

Sanhai, W. R., Sakamoto, J. H., Canady, R., & Mauro Ferrari, B. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.114 · Cited by 538 · see citing works

Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects

Yoo, J., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 522 · see citing works

Paclitaxel: a review of adverse toxicities and novel delivery strategies

Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 509 · see citing works

A robustness-based approach to systems-oriented drug design

Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488 · see citing works

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications

Bar‐Sela, G., Epelbaum, R., & Schaffer, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710790149738 · Cited by 479 · see citing works

Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death

Noh, J., Kwon, B., Han, E., Park, M., Yang, W., Cho, W., Yoo, W., Khang, G., & Lee, D. (2015) · Nature Communications · doi:10.1038/ncomms7907 · Cited by 462 · see citing works

Cisplatin: a review of toxicities and therapeutic applications

Barabas, K., Milner, R. J., Lurie, D. M., & Adin, C. A. (2008) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2007.00142.x · Cited by 449 · see citing works

Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

Meng, H., Wang, M., Liu, H., Liu, X., Situ, A., Wu, B., Ji, Z., Chang, C. H., & Nel, A. E. (2015) · ACS Nano · doi:10.1021/acsnano.5b00510 · Cited by 440 · see citing works

Taxol (paclitaxel): mechanisms of action.

Horwitz, S. B. (1994) · PubMed · Cited by 420 · see citing works

Stimuli-responsive nanomaterials for therapeutic protein delivery

Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415 · see citing works

Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin

Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411 · see citing works

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

Song, Y., Yue, Z.-Y., Wang, Z.-N., Xu, Y., Luo, Y., Xu, H., Zhang, X., Jiang, L., Xing, C., & Zhang, Y. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-1 · Cited by 392 · see citing works

Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy

Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.057 · Cited by 385 · see citing works

Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications

Shim, M. S., & Kwon, Y. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.018 · Cited by 384 · see citing works

Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram

Duan, X., Xiao, J., Yin, Q., Zhang, Z., Yu, H., Mao, S., & Li, Y. (2013) · ACS Nano · doi:10.1021/nn4010796 · Cited by 378 · see citing works

Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2)

Granado‐Serrano, A. B., Martiín, M. A., Bravo, L., Goya, L., & Ramos, S. (2006) · Journal of Nutrition · doi:10.1093/jn/136.11.2715 · Cited by 374 · see citing works

Excisional surgery for cancer cure: therapy at a cost

Coffey, J., Wang, J., Smith, M., Bouchier-Hayes, D. A., Cotter, T. G., & Redmond, H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01282-8 · Cited by 373 · see citing works

A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin

Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., & Johnson, J. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502011g · Cited by 365 · see citing works

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

Lv, S., Tang, Z., Li, M., Lin, J., Song, W., Liu, H., Huang, Y., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.034 · Cited by 346 · see citing works

Accelerating the Translation of Nanomaterials in Biomedicine

Mitragotri, S., Anderson, D. G., Chen, X. S., Chow, E. K., Ho, D., Kabanov, A. V., Karp, J. M., Kataoka, K., Mirkin, C. A., Petrosko, S. H., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03569 · Cited by 346 · see citing works

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug

Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340 · see citing works

Why is cancer drug discovery so difficult?

Kamb, A., Wee, S., & Lengauer, C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2155 · Cited by 339 · see citing works

Synergy, additivism and antagonism in immunosuppression. A critical review.

Berenbaum, M. C. (1977) · PubMed · Cited by 334 · see citing works

Transport into and out of the cell nucleus

Görlich, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2721 · Cited by 333 · see citing works

Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery

Sun, W., Jiang, T., Lü, Y., Reiff, M., Mo, R., & Gu, Z. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5088024 · Cited by 329 · see citing works

Building drug delivery into tissue engineering design

Saltzman, W. M., & Olbricht, W. L. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd744 · Cited by 317 · see citing works

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature

Downing, M. G., Sanfilippo, A., Maruff, P. T., Weih, L. M., & Phillips, K. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 314 · see citing works

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C. E., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310 · see citing works

Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood

Setyawati, M. I., Tay, C. Y., Docter, D., Stauber, R. H., & Leong, D. T. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00499c · Cited by 308 · see citing works

Single agent versus combination chemotherapy for metastatic breast cancer

Carrick, S. E., Parker, S. K., Thornton, C. E., et al. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub3 · Cited by 307 · see citing works

Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy

Jiang, T., Mo, R., Bellotti, A., Zhou, J., & Gu, Z. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303222 · Cited by 297 · see citing works

Review: Nuclear Events in Apoptosis

Robertson, J. D., Orrenius, S., & Zhivotovsky, B. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4254 · Cited by 284 · see citing works

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study

Bergh, J. C. S., Bondarenko, I. M., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N. L., Makhson, A. N., Cortés, J., Lortholary, A. H., Bischoff, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7376 · Cited by 264 · see citing works

Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin

Li, M., Tang, Z., Lv, S., Song, W., Hong, H., Jing, X., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.018 · Cited by 262 · see citing works

Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates

Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F., Basto, P. A., Bagalkot, V., Jon, S., Langer, R., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257 · see citing works

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

Lammers, T., Šubr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240 · see citing works

Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced Toxicity

Jain, A., Thanki, K., & Jain, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400311j · Cited by 235 · see citing works

Gemcitabine—a safety review

Aapro, M., Martin, C., & Hatty, S. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199803000-00001 · Cited by 230 · see citing works

Topical chemotherapy with 5-fluorouracil

Goette, D. K. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)80196-x · Cited by 228 · see citing works

Furin‐Mediated Sequential Delivery of Anticancer Cytokine and Small‐Molecule Drug Shuttled by Graphene

Jiang, T., Sun, W., Zhu, Q., Burns, N. A., Khan, S. A., Mo, R., & Gu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201404498 · Cited by 228 · see citing works

Paclitaxel (Taxol®): A success story with valuable lessons for natural product drug discovery and development

Cragg, G. M. L. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5 · Cited by 217 · see citing works

Optimizing Combination Chemotherapy by Controlling Drug Ratios

Mayer, L. D., & Janoff, A. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.4.8 · Cited by 214 · see citing works

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors

Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 214 · see citing works

Polymer-Caged Nanobins for Synergistic Cisplatin−Doxorubicin Combination Chemotherapy

Lee, S., O’Halloran, T. V., & Nguyen, S. T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107333g · Cited by 213 · see citing works

Drug delivery from structured porous inorganic materials

Arruebo, M. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.132 · Cited by 213 · see citing works

Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles

Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 210 · see citing works

Neurotoxicity of Taxol.

Rowinsky, E. K., Chaudhry, V., Cornblath, D. R., & Donehower, R. C. (1993) · PubMed · Cited by 208 · see citing works

Recent advances in delivery of drug–nucleic acid combinations for cancer treatment

Li, J., Wang, Y., Zhu, Y. T., & Oupický, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.010 · Cited by 207 · see citing works

A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance

Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.049 · Cited by 200 · see citing works

Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy

Aryal, S., Hu, C. J., & Zhang, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200243k · Cited by 200 · see citing works

A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways

Morton, S. W., Lee, M. J., Deng, Z. J., Dreaden, E. C., Siouve, E., Shopsowitz, K. E., Shah, N. J., Yaffe, M. B., & Hammond, P. T. (2014) · Science Signaling · doi:10.1126/scisignal.2005261 · Cited by 190 · see citing works

Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery

Aryal, S., Hu, C. J., & Zhang, L. (2010) · Small · doi:10.1002/smll.201000631 · Cited by 183 · see citing works

Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives

Mullangi, R., Ahlawat, P., & Srinivas, N. R. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1345 · Cited by 180 · see citing works

Nanoparticles with Precise Ratiometric Co‐Loading and Co‐Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

Miao, L., Guo, S., Zhang, J., Kim, W. Y., & Huang, L. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201401076 · Cited by 178 · see citing works

Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents

Bae, Y., Diezi, T. A., Zhao, A., & Kwon, G. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.038 · Cited by 173 · see citing works

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells

Sun, R., Liu, Y., Li, S.-Y., Shen, S., Du, X.-J., Xu, C.-F., Cao, Z.-T., Bao, Y., Zhu, Y.-H., Li, Y.-P., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.018 · Cited by 172 · see citing works

Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review

Lotfi‐Jam, K., Carey, M. L., Jefford, M., Schofield, P. E., Charleson, C., & Aranda, S. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9053 · Cited by 169 · see citing works

Nanoparticles containing insoluble drug for cancer therapy

Guo, S., & Huang, L. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.002 · Cited by 159 · see citing works

Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles

Liu, D., Bimbo, L. M., Mäkilä, E. M., Villanova, F., Kaasalainen, M. H., Herranz‐Blanco, B., Caramella, C. M., Lehto, V., Salonen, J., Herzig, K., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.036 · Cited by 156 · see citing works

P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines

Nielsen, D. L., & Skovsgaard, T. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90131-6 · Cited by 156 · see citing works

Exploring the Tumor Microenvironment with Nanoparticles

Miao, L., & Huang, L. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_9 · Cited by 154 · see citing works

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

Cai, L., Xu, G., Shi, C., Guo, D., Wang, X., & Luo, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.044 · Cited by 151 · see citing works

Review of Tests for Monitoring Doxorubicin-lnduced Cardiomyopathy

Ganz, W. I., Sridhar, K. S., Ganz, S. S., et al. (2009) · Oncology · doi:10.1159/000227621 · Cited by 151 · see citing works

Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers

Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 148 · see citing works

Programmable nanomedicine: synergistic and sequential drug delivery systems

Pacardo, D. B., Ligler, F. S., & Gu, Z. (2015) · Nanoscale · doi:10.1039/c4nr07677j · Cited by 142 · see citing works

Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

Belani, C. P., Ramalingam, S. S., Perry, M. C., LaRocca, R. V., Rinaldi, D. A., Gable, P. S., & Tester, W. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1912 · Cited by 142 · see citing works

Engineering Inorganic Nanoemulsions/Nanoliposomes by Fluoride‐Silica Chemistry for Efficient Delivery/Co‐Delivery of Hydrophobic Agents

Chen, Y., Gao, Y., Chen, H., Zeng, D., Li, Y., Zheng, Y., Li, F., Ji, X., Wang, X., Chen, F., et al. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201102052 · Cited by 141 · see citing works

Cancer immunotherapy: breaking the barriers to harvest the crop

Pardoll, D. M., & Allison, J. P. (2004) · Nature Medicine · doi:10.1038/nm0904-887 · Cited by 135 · see citing works

Discussion

Fan, W. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00006-4 · Cited by 135 · see citing works

Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature

Barui, S., Saha, S., Mondal, G., Haseena, S., & Chaudhuri, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.074 · Cited by 134 · see citing works

Origins of cancer therapy.

Papac, R. J. (2002) · PubMed · Cited by 124 · see citing works

Antimalarial drug synergism and antagonism: Mechanistic and clinical significance

Bell, A. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.035 · Cited by 119 · see citing works

Single agent versus combination chemotherapy for metastatic breast cancer

Carrick, S. E., Parker, S. K., Thornton, C. E., et al. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub2 · Cited by 118 · see citing works

Multiple Layer‐by‐Layer Lipid‐Polymer Hybrid Nanoparticles for Improved FOLFIRINOX Chemotherapy in Pancreatic Tumor Models

Li, F., Zhao, X. L., Wang, H., Zhao, R., Ji, T., Ren, H., Anderson, G. J., Nie, G., & Hao, J. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201401583 · Cited by 114 · see citing works

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer

Desale, S. S., Cohen, S. M., Zhao, Y., Kabanov, A. V., & Bronich, T. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.026 · Cited by 110 · see citing works

Pharmacological basis of pegylated liposomal doxorubicin: Impact on cancer therapy

Gabizón, A., Shmeeda, H., & Grenader, T. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.006 · Cited by 109 · see citing works

Blockage of Drug Resistance In Vitro by Disulfiram, a Drug Used to Treat Alcoholism

Loo, T. W. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.898 · Cited by 107 · see citing works

Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)

Yang, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1675 · Cited by 97 · see citing works

Doxorubicin (adriamycin) cardiomyopathy.

Saltiel, E., & McGuire, W. P. (1983) · PubMed · Cited by 94 · see citing works

A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery

Zhong, J., Li, L., Zhu, X. D., Guan, S., Yang, Q., Zhou, Z., Zhang, Z., & Huang, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.042 · Cited by 93 · see citing works

Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer

Stegh, A. H., Petrosko, S. H., Meade, T. J., & Mirkin, C. A. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4 · Cited by 93 · see citing works

Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance

Jia, L., Li, Z., Shen, J., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.010 · Cited by 91 · see citing works

An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform

Wang, W., Song, H., Zhang, J., Li, P., Li, C., Wang, C., Kong, D., & Zhao, Q. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.015 · Cited by 91 · see citing works

Sizing up targets with nanoparticles

Minchin, R. F. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2007.433 · Cited by 90 · see citing works

Uncoupling between Epidermal Growth Factor Receptor and Downstream Signals Defines Resistance to the Antiproliferative Effect of Gefitinib in Bladder Cancer Cells

Kassouf, W., Dinney, C. P., Brown, G. A., McConkey, D. J., Diehl, J. A., Bar‐Eli, M., & Adam, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1536 · Cited by 87 · see citing works

Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study

Gradishar, W. J., Meza, L. A., Amin, B., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.128 · Cited by 86 · see citing works

Disulfiram Metabolites Permanently Inactivate the Human Multidrug Resistance P-Glycoprotein

Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049917l · Cited by 80 · see citing works

Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs

Tai, W., Mo, R., Lü, Y., Jiang, T., & Gu, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.004 · Cited by 78 · see citing works

Adverse effects of the humanized antibodies used as cancer therapeutics

Klastersky, J. A. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000228734.32261.62 · Cited by 75 · see citing works

Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A review

Guchelaar, H., ten Napel, C. H. H., de Vries, E. G. E., et al. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80367-x · Cited by 75 · see citing works

Retinoic Acid and the Histone Deacetylase Inhibitor Trichostatin A Inhibit the Proliferation of Human Renal Cell Carcinoma in a Xenograft Tumor Model

Touma, S. E., Goldberg, J. S., Moench, P. A., Guo, X., Tickoo, S. K., Gudas, L. J., & Nanus, D. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1155 · Cited by 75 · see citing works

Recent Progress in Multidrug Delivery to Cancer Cells by Liposomes

Mo, R., Jiang, T., & Gu, Z. N. (2014) · Nanomedicine · doi:10.2217/nnm.14.62 · Cited by 62 · see citing works

Engineering DNA scaffolds for delivery of anticancer therapeutics

Sun, W., & Gu, Z. (2015) · Biomaterials Science · doi:10.1039/c4bm00459k · Cited by 61 · see citing works

Lipid‐Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo

Dong, Y., Eltoukhy, A. A., Alabi, C. A., Khan, O. F., Omid Veiseh, A., Dorkin, J. R., Sirirungruang, S., Yin, H., Tang, B. C., Pelet, J. M., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400054 · Cited by 60 · see citing works

The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review

Dingle, B., Rumble, R. B., & Brouwers, M. C. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/565479 · Cited by 57 · see citing works

Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer

Honecker, F. U., Kollmannsberger, C., Quietzsch, D., et al. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200206000-00008 · Cited by 52 · see citing works

Crosstalk of oncogenic and prostanoid signaling pathways

M�ller, R. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0570-y · Cited by 47 · see citing works

Acid-degradable core–shell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD)

Cho, S. K., Pedram, A., Levin, E. R., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.003 · Cited by 47 · see citing works

Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children

Ribeiro, R. C., Pui, C., & Schell, M. J. (1988) · Cancer · doi:10.1002/1097-0142(19880201)61:3 · Cited by 44 · see citing works

Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies

Mills, E. J., Thorlund, K., & Ioannidis, J. P. A. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.07.012 · Cited by 44 · see citing works

Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.

Maciejczyk, A., Łacko, A., Ekiert, M., Jagoda, E., Wysocka, T., Matkowski, R., Hałoń, A., Győrffy, B., Lage, H., & Surowiak, P. (2013) · PubMed · doi:10.14670/hh-28.513 · Cited by 36 · see citing works

Advances in Anticancer Protein Delivery using Micro‐/Nanoparticles

Sun, W., Lü, Y., & Gu, Z. (2014) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201400140 · Cited by 33 · see citing works

Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes

Tanabe, M., Ito, Y., Tokudome, N., et al. (2009) · Breast Cancer · doi:10.1007/s12282-009-0093-0 · Cited by 28 · see citing works

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer

Hu, X., Wang, B., Sun, S., Tang, L., Zhang, J., Lv, F., Wang, Z., Wang, L., Zhang, Q., Zheng, C., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s58275 · Cited by 24 · see citing works

Bispecific antibody-mediated lysis of primary cultures of ovarian carcinoma cells using multiple target antigens

Smans, K. A., Ingvarsson, M. B., Lindgren, P., Canevari, S., Walt, H., Stigbrand, T. I., m, T. R. B. C., & Mill�n, J. L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2 · Cited by 14 · see citing works

Chlorambucil in the treatment of patients with immune‐mediated rheumatic diseases

Steinberg, A. D. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360306 · Cited by 13 · see citing works

Combinatorial Nanotherapeutics: Rewiring, Then Killing, Cancer Cells

Fang, R. H., & Zhang, L. (2014) · Science Signaling · doi:10.1126/scisignal.2005386 · Cited by 12 · see citing works

Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699 · see citing works

Viral Nanoparticles for Drug Delivery, Imaging, Immunotherapy, and Theranostic Applications

Chung, Y. H., Cai, H., & Steinmetz, N. F. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.024 · Cited by 391 · see citing works

Nanoformulations for combination or cascade anticancer therapy

Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178 · see citing works

Physico-chemical strategies to enhance stability and drug retention of polymeric micelles for tumor-targeted drug delivery

Shi, Y., Lammers, T., Storm, G., & Hennink, W. E. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201600160 · Cited by 174 · see citing works

Combination therapy based on nano codelivery for overcoming cancer drug resistance

Wang, H., & Huang, Y. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100024 · Cited by 115 · see citing works

Delivery Strategies for Immune Checkpoint Blockade

Chen, Q., Wang, C., Chen, G., Hu, Q., & Gu, Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800424 · Cited by 90 · see citing works

Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer

Lei, F., Xi, X., Batra, S. K., & Bronich, T. K. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255786 · Cited by 51 · see citing works

Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System

Zhang, G., Chen, L., Guo, X., et al. (2016) · Current Organic Chemistry · doi:10.2174/1385272820666161017170325 · Cited by 6 · see citing works

Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery

Kralj, S., Potrč, T., Kocbek, P., Marchesan, S., & Makovec, D. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160813211736 · Cited by 84 · see citing works

Targeted Drug Delivery

(2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8661-3 · Cited by 3 · see citing works

An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems

Cano‐Cortés, V., Altea‐Manzano, P., Laz-Ruiz, J. A., et al. (2021) · Nanoscale · doi:10.1039/d0nr07145e · Cited by 12 · see citing works

Application and Perspective of pH-Responsive Nano Drug Delivery Systems

Goyal, A. K., Rath, G., Faujdar, C., & Malik, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00002-8 · Cited by 26 · see citing works